01 March 2021
The ATS Xtend™ Offline system automates essential steps of your dissolution test - making them highly repeatable. Samples are simultaneously taken from 6-8 vessels, filtered, and collected in tubes, capped LC vials, or wellplates.
read more
15 January 2021
Don't miss out when pharmaceutical testing experts exchange their views on current market challenges from 21 - 22 September 2021. Speakers include renowned experts from academia, industry, and regulatory agencies.
read more
25 May 2020
Connect one or multiple manual AT Xtend™ dissolution baths to a q-doc® workstation for full traceability of user actions. Started tests continue in case of network interruptions and all test results are protocolled in one location.
read more
10 May 2020
Conducted every year, this flagship conference will be attended by Pharmaceutical R&D, QA, and QC as well as academia professionals and speakers from US, Europe and Asia.
read more
01 May 2020
The SOTAX Group takes over the software specialist SECOM GmbH to further expand its position as the world's leading solution provider for pharmaceutical test equipment.
read more
26 March 2020
SOTAX continue to operate and remain accessible to customers and partners: We maintain sales, production, logistics, and all our services.
read more
01 November 2019
Driving prediction forward – SOTAX announces partnership with Triskelion for In-vivo Predictive Dissolution Testing
read more
01 July 2019
Two new dissolution course offerings operated by USP in cooperation with SOTAX at our Corporate Headquarters in Aesch/Basel, Switzerland.
read more
10 May 2019
From 7-9 May, more than 40 local experts & SOTAX partners from all over Asia participated in laboratory automation & data integrity workshops - covering dissolution testing, tablet hardness testing, and automated sample preparation in Phuket, Thailand.
read more
01 May 2019
The flow-through cell dissolution method (USP <711>, Apparatus 4 / Ph. Eur. 2.9.3, Apparatus 4) is a well-known approach for low-solubility BCS Class II and IV active pharmaceutical ingredients (APIs) and their drug products.
read more